Image

Ulixertinib/Palbociclib in Patients With Advanced Pancreatic and Other Solid Tumors

Investigating Safety and Dosage of Investigational Treatment in Advanced Solid Tumors

Recruiting
18-99 years
All
Phase 1
  • Simplified description (AI rewritten)
  • Technical description (Original)

The purpose of this study is to investigate advanced pancreatic and other solid tumors. This study investigates how patients with these conditions respond to an investigational medication.

This study evaluates the safety and appropriate dosage levels of the investigational medication. It is focused on understanding the effects of combining different treatments for these tumors.

  • Who can participate: Adults aged 18 and older with advanced solid tumors that are not responding to standard treatments can join. Participants must meet specific health criteria and have a life expectancy of at least 12 weeks.
  • Study details: Participants will receive an investigational medication to assess its safety and dosage levels.
Print
Study details
    Tumor
    Solid
    Pancreatic Cancer
    Melanoma

NCT03454035

UNC Lineberger Comprehensive Cancer Center

29 August 2026

Contact a study center
Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Email

View email

Phone

Phone country flag

View phone
Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.